GG
TDOC icon

Gleason Group’s Teladoc Health TDOC Stock Holding History

Gleason Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-324
Closed -$30K – 218
2021
Q4 		$30K Hold
324
– – 0.01% 128
2021
Q3 		$41K Hold
324
– – 0.01% 121
2021
Q2 		$54K Hold
324
– – 0.02% 105
2021
Q1 		$59K Hold
324
– – 0.02% 96
2020
Q4 		$65K Hold
324
– – 0.03% 86
2020
Q3 		$71K Sell
324
-24
-7% -$5.08K 0.04% 78
2020
Q2 		$66K Sell
348
-134
-28% -$23.5K 0.04% 80
2020
Q1 		$75K Buy
482
+32
+7% +$3.72K 0.06% 68
2019
Q4 		$38K Buy
+450
New +$34.2K 0.02% 117

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gleason Group's TDOC Position: Q1 2022 in Review

Gleason Group sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 324 shares — an estimated $30K sold.

Gleason Group first reported a position in TDOC in Q4 2019 and held it in 9 quarters. The position peaked at $75K in Q1 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Gleason Group reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Gleason Group sold 324 Teladoc Health shares in Q1 2022, an estimated $30K.
  • Gleason Group first reported a position in Teladoc Health in Q4 2019 and held it in 9 quarters.
  • Gleason Group's Teladoc Health position peaked at $75K in Q1 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Gleason Group's 13F filing for Q1 2022, filed 22 Apr 2022.